| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2863124 | The American Journal of the Medical Sciences | 2016 | 7 Pages |
Abstract
Initial induction failure or poorer prognostic stratification seriously affected the survival of patients with de novo AML. The allogeneic hematopoietic cell transplant is an alternative strategy to improve the survival of patients resistant to initial treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sijing MS, Shijia MS, Li MS, Ying MS, Yicheng MD, Jianfeng MD, Dengju MD,